Perioperative, protective use of extracorporeal membrane oxygenation in complex thoracic surgery.

Abstract

BACKGROUND\nExtracorporeal membrane oxygenation (ECMO) is increasingly used in patients undergoing complex thoracic surgical procedures. However, studies reporting the clinical outcomes of these patients are limited to case reports, without real consensus. Our aim was to evaluate the perioperative use of ECMO as respiratory and/or circulatory support in thoracic surgery: indications, benefits, and perioperative management.\n\n\nMETHODS\nBetween May 2013 and December 2018, we reviewed the clinical data of 15 patients (11 males and 4 females; mean age: 47\u2009years old; range, 25-73\u2009years) undergoing ECMO-assisted thoracic surgery in our hospital.\n\n\nRESULTS\nOf the 15 patients, 10 cases received peripheral veno-arterial (VA) ECMO and five cases received veno-venous (VV) ECMO. Indications for ECMO were pulmonary transplantation with hard-to-maintain oxygenation (n\u2009=\u20095), traumatic main bronchial rupture (n\u2009=\u20092), traumatic lung injury (n\u2009=\u20091), airway tumor leading to severe airway stenosis (n\u2009=\u20092), huge thoracic mass infiltrated vena cava (n\u2009=\u20095). The ECMO duration was 1-51\u2009hours. All patients were successfully extubated and weaned from ECMO postoperatively. The main complications were hemorrhage (26.7%), infection (33.3%), acute hepatic dysfunction (33.3%), and venous thrombosis (26.7%). There was only one hospital death and postoperative one-year survival rate was 86%.\n\n\nCONCLUSION\nOur experience indicates that ECMO is a feasible method for complex trachea-bronchial surgery, huge thoracic mass excision and lung transplantation, and the ECMO-related risks may be justified. With further accumulation of experience with ECMO, a more sophisticated protocol for management of critical airway or heart failure problems in thoracic surgeries can be derived.